Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05309733 · ClinicalTrials.gov registry record
A Long-term Follow-up Study of Patients Who Received VOR33
A clinical trial, sponsored by Vor Biopharma.
- Terminated
- Registry status
- 10
- Enrollment target
NCT05309733: Clinical Trial study, sponsored by Vor Biopharma.
NCT05309733 is a clinical trial that was terminated before completion, run by Vor Biopharma. The registered enrollment target is 10 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05309733 was terminated before completion, sponsored by Vor Biopharma.
- TERMINATED
- Registry status
- 10 participants
- Enrollment target
Study Summary
VOR33 long-term follow-up (LTFU) study
Primary Outcome
Incidence of VOR33-related AEs/SAEs or deaths.
Interventions
- GENETIC VOR33
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2022-04-15 |
| Est. Completion | 2025-05-28 |
Why NCT05309733 stopped before completion
NCT05309733 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 10 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which VOR33 is the first listed.
NCT05309733 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05309733 about?
NCT05309733 is a clinical study titled "A Long-term Follow-up Study of Patients Who Received VOR33". VOR33 long-term follow-up (LTFU) study
What is the current status of trial NCT05309733?
This trial is currently terminated. The enrollment target is 10 participants. The study started on 2022-04-15. Estimated completion is 2025-05-28.
What interventions are being tested in trial NCT05309733?
The interventions under investigation include: VOR33 (GENETIC).
Who is sponsoring clinical trial NCT05309733?
This trial is sponsored by Vor Biopharma, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI